Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1953 1
1954 1
1957 1
1959 2
1961 1
1962 1
1968 1
1977 4
1978 1
1979 1
1980 2
1981 1
1982 1
1984 2
1985 1
1986 2
1988 2
1989 1
1991 4
1992 3
1993 2
1994 1
1995 2
1996 2
1997 7
1998 5
1999 6
2000 6
2001 6
2002 4
2003 4
2004 7
2005 12
2006 8
2007 12
2008 13
2009 20
2010 18
2011 30
2012 34
2013 45
2014 45
2015 53
2016 36
2017 50
2018 53
2019 57
2020 70
2021 74
2022 63
2023 66
2024 55

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

783 results

Results by year

Filters applied: . Clear all
Page 1
Postictal thoracocervicofacial purpura.
de Souza PVS, Bortholin T, de Rezende Pinto WBV, Santos AJ. de Souza PVS, et al. Pract Neurol. 2017 Aug;17(4):306. doi: 10.1136/practneurol-2017-001633. Epub 2017 Apr 20. Pract Neurol. 2017. PMID: 28428228 No abstract available.
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. Among authors: de souza p. Lancet Oncol. 2015 Feb;16(2):152-60. doi: 10.1016/S1470-2045(14)71205-7. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601341 Clinical Trial.
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bähr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M. Reardon DA, et al. Among authors: de souza p. JAMA Oncol. 2020 Jul 1;6(7):1003-1010. doi: 10.1001/jamaoncol.2020.1024. JAMA Oncol. 2020. PMID: 32437507 Free PMC article. Clinical Trial.
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors.
Rottey S, Clarke J, Aung K, Machiels JP, Markman B, Heinhuis KM, Millward M, Lolkema M, Patel SP, de Souza P, Duca M, Curigliano G, Santoro A, Koyama T, Brown M, Vezina H, He C, Chu QS. Rottey S, et al. Among authors: de souza p. Clin Cancer Res. 2022 Jan 1;28(1):95-105. doi: 10.1158/1078-0432.CCR-21-1181. Epub 2021 Oct 6. Clin Cancer Res. 2022. PMID: 34615718 Free PMC article. Clinical Trial.
Neutrophils: fast and furious-the nucleotide pathway.
Rubenich DS, de Souza PO, Omizzollo N, Lenz GS, Sevigny J, Braganhol E. Rubenich DS, et al. Among authors: de souza po. Purinergic Signal. 2021 Sep;17(3):371-383. doi: 10.1007/s11302-021-09786-7. Epub 2021 Apr 29. Purinergic Signal. 2021. PMID: 33913070 Free PMC article. Review.
Chalcones against the hallmarks of cancer: a mini-review.
de Souza PS, Bibá GCC, Melo EDDN, Muzitano MF. de Souza PS, et al. Nat Prod Res. 2022 Sep;36(18):4809-4826. doi: 10.1080/14786419.2021.2000980. Epub 2021 Dec 6. Nat Prod Res. 2022. PMID: 34865580 Review.
Reticular erythematous mucinosis.
Haendchen LC, Sabbag DS, Furlani Wde J, de Souza PK, Rotta O. Haendchen LC, et al. Among authors: de souza pk. Cutis. 2014 Mar;93(3):E21-4. Cutis. 2014. PMID: 24738106 No abstract available.
Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression.
Rubenich DS, de Souza PO, Omizzollo N, Aubin MR, Basso PJ, Silva LM, da Silva EM, Teixeira FC, Gentil GFS, Domagalski JL, Cunha MT, Gadelha KA, Diel LF, Gelsleichter NE, Rubenich AS, Lenz GS, de Abreu AM, Kroeff GM, Paz AH, Visioli F, Lamers ML, Wink MR, Worm PV, Araújo AB, Sévigny J, Câmara NOS, Ludwig N, Braganhol E. Rubenich DS, et al. Among authors: de souza po. Front Immunol. 2023 May 24;14:1183465. doi: 10.3389/fimmu.2023.1183465. eCollection 2023. Front Immunol. 2023. PMID: 37292196 Free PMC article.
783 results